Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levocetirizine vs Loratadine in Perennial Allergic Rhinitis
NCT00524836Phase 3Completed
- Sponsor
- UCB
- Start
- Sep 2003
- Primary completion
- Feb 2004
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of levocetirizine in perennial allergic rhinitis (PAR), sponsored by UCB. Started Sep 2003; status: completed.
02
Drugs
levocetirizine
03
Conditions
perennial allergic rhinitis (PAR)
Beyond the preview
Go deeper on NCT00524836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00524836.